We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+7.05%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$131B
AUM Growth
+$13.8B
(+12%)
Cap. Flow
+$6.04B
Cap. Flow
% of AUM
4.61%
Top 10 Holdings %
Top 10 Hldgs %
44.72%
Holding
4,042
New
364
Increased
2,601
Reduced
814
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$740M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$544M |
| 3 |
NVIDIA
NVDA
|
+$407M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$325M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$276M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$232M |
| 2 |
Vanguard Large-Cap ETF
VV
|
+$58.3M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$46.4M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$40M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$37.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.26% |
| 2 | Financials | 3.77% |
| 3 | Consumer Discretionary | 2.12% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
PUT
Meta Platforms (Facebook)
META
$1.51T
| $27K | ﹤0.01% |
1,900
+700
| +58% | +$521K |
|
3802
Aemetis
AMTX
$119M
| $26.2K | ﹤0.01% |
11,650
-535
| -4% | -$1.42K |
|
|
FURY
3803
Fury Gold Mines
FURY
$98.9M
| $26K | ﹤0.01% |
39,781
+29,376
| +282% | +$16.6K |
|
3804
Pulmonx
LUNG
$49.4M
| $25.7K | ﹤0.01% |
15,850
+2,514
| +19% | +$5.26K |
|
|
PGYWW
3805
Pagaya Technologies Ltd Warrants
PGYWW
$1.37M
| $25K | ﹤0.01% |
50,000
| – | – |
|
3806
Biomea Fusion
BMEA
$90.4M
| $24.7K | ﹤0.01% |
12,228
-900
| -7% | -$1.65K |
|
3807
PUT
Microsoft
MSFT
$2.84T
| $24K | ﹤0.01% |
10,600
-300
| -3% | -$153K |
|
|
ZEO
3808
Zeo Energy
ZEO
$19.1M
| $23.3K | ﹤0.01% |
+17,278
| New | +$34.8K |
|
|
ZTEK
3809
Zentek
ZTEK
$67.3M
| $23.2K | ﹤0.01% |
+30,349
| New | +$26.7K |
|
3810
Polestar Automotive Holding UK
PSNY
$1.98B
| $23K | ﹤0.01% |
816
+176
| +28% | +$5.64K |
|
|
RUMBW
3811
RUM Group Inc Warrant
RUMBW
$12.1M
| $22.9K | ﹤0.01% |
11,500
+1,000
| +10% | +$2.51K |
|
3812
Cerus
CERS
$587M
| $22.3K | ﹤0.01% |
+14,056
| New | +$19K |
|
3813
CALL
SPDR Gold Trust
GLD
$131B
| $21.8K | ﹤0.01% |
400
| – | – |
|
3814
PUT
Broadcom
AVGO
$1.82T
| $21.7K | ﹤0.01% |
6,900
+2,500
| +57% | +$767K |
|
3815
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $21.6K | ﹤0.01% |
16,000
+14,900
| +1,355% | +$9.55M |
|
3816
Valens Semiconductor
VLN
$176M
| $21.2K | ﹤0.01% |
11,864
-69,085
| -85% | -$156K |
|
|
SSKN
3817
DELISTED
Strata Skin Sciences
SSKN
| $20.6K | ﹤0.01% |
10,016
| – | – |
|
3818
Westwater Resources
WWR
$51M
| $20.4K | ﹤0.01% |
21,500
+5,000
| +30% | +$3.76K |
|
3819
Cytosorbents Corp
CTSO
$22.6M
| $20K | ﹤0.01% |
21,455
-660
| -3% | -$650 |
|
3820
PUT
Deere & Co
DE
$170B
| $20K | ﹤0.01% |
2,900
| – | – |
|
|
ONCY
3821
Oncolytics Biotech
ONCY
$96.9M
| $18.7K | ﹤0.01% |
13,330
| – | – |
|
3822
Solitario Resources
XPL
$68.1M
| $17.8K | ﹤0.01% |
25,500
+500
| +2% | +$361 |
|
|
BNKK
3823
Bonk Inc
BNKK
$8.96M
| $16.3K | ﹤0.01% |
1,742
-202
| -10% | -$3.69K |
|
3824
Heron Therapeutics
HRTX
$86.3M
| $15.6K | ﹤0.01% |
12,409
-26,980
| -68% | -$42.8K |
|
3825
Marker Therapeutics
MRKR
$20.3M
| $15.5K | ﹤0.01% |
17,312
| – | – |
|
Similar funds
Creative Planning's Q3 2025 Portfolio in Review
As of Q3 2025, Creative Planning held 4,042 positions worth $131B, up 12% from $117B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning deployed $6.04B of net new capital in Q3 2025, opening 364 new positions and adding to 2,601 existing holdings. Its largest new stake was Amrize Ltd: 170,878 shares worth $8.29M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $232M trimmed.
- Creative Planning's largest Q3 2025 buy was Amrize Ltd: 170,878 shares worth $8.29M.
- Creative Planning added most to Vanguard Total Bond Market in Q3 2025, an estimated $740M increase.
- Creative Planning's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $232M.
- Creative Planning fully exited Ansys in Q3 2025, selling an estimated $4.86M.
- Creative Planning's ten largest holdings make up 45% of its $131B portfolio in Q3 2025.
- Creative Planning opened 364 new positions and closed 133 in Q3 2025.
- Creative Planning's portfolio value rose 12% quarter-over-quarter to $131B.
Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.